Journal
BLOOD
Volume 110, Issue 4, Pages 1343-1352Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2007-01-068635
Keywords
-
Categories
Funding
- NHLBI NIH HHS [R01 HL073431, HL52243, R01 HL052243, R01 HL073442, HL73442, HL73431] Funding Source: Medline
Ask authors/readers for more resources
The mechanisms underlying the human fetal-to-adult beta-globin gene switch remain to be determined. While there is substantial experimental evidence to suggest that promoter DNA methylation is involved in this process, most data come from studies in nonhuman systems. We have evaluated human gamma- and beta-globin promoter methylation in primary human fetal liver (FL) and adult bone marrow (ABM) erythroid cells. Our results show that, in general, promoter methylation and gene expression are inversely related. However, CpGs at - 162 of they promoter and -126 of the 0 promoter are hypomethylated in ABM and FL, respectively. We also studied gamma-globin promoter methylation during in vitro differentiation of erythroid cells. The gamma promoters are initially hypermethylated in CD34(+) cells. The upstream gamma promoter CpGs become hypomethylated during the preerythroid phase of differentiation and are then remethylated later, during erythropolesis. The period of promoter hypomethylation correlates with transient gamma-globin gene expression and may explain the previously observed fetal hemoglobin production that occurs during early adult erythropoiesis. These results provide the first comprehensive survey of developmental changes in human gamma- and R-globin promoter methylation and support the hypothesis that promoter methylation plays a role in human beta-globin locus gene switching.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available